Cargando…

Translation, adaptation and validation of the American short form Patient Activation Measure (PAM13) in a Danish version

BACKGROUND: The Patient Activation Measure (PAM) is a measure that assesses patient knowledge, skill, and confidence for self-management. This study validates the Danish translation of the 13-item Patient Activation Measure (PAM13) in a Danish population with dysglycaemia. METHODS: 358 people with s...

Descripción completa

Detalles Bibliográficos
Autores principales: Maindal, Helle Terkildsen, Sokolowski, Ineta, Vedsted, Peter
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2712471/
https://www.ncbi.nlm.nih.gov/pubmed/19563630
http://dx.doi.org/10.1186/1471-2458-9-209
_version_ 1782169492610088960
author Maindal, Helle Terkildsen
Sokolowski, Ineta
Vedsted, Peter
author_facet Maindal, Helle Terkildsen
Sokolowski, Ineta
Vedsted, Peter
author_sort Maindal, Helle Terkildsen
collection PubMed
description BACKGROUND: The Patient Activation Measure (PAM) is a measure that assesses patient knowledge, skill, and confidence for self-management. This study validates the Danish translation of the 13-item Patient Activation Measure (PAM13) in a Danish population with dysglycaemia. METHODS: 358 people with screen-detected dysglycaemia participating in a primary care health education study responded to PAM13. The PAM13 was translated into Danish by a standardised forward-backward translation. Data quality was assessed by mean, median, item response, missing values, floor and ceiling effects, internal consistency (Cronbach's alpha and average inter-item correlation) and item-rest correlations. Scale properties were assessed by Rasch Rating Scale models. RESULTS: The item response was high with a small number of missing values (0.8–4.2%). Floor effect was small (range 0.6–3.6%), but the ceiling effect was above 15% for all items (range 18.6–62.7%). The α-coefficient was 0.89 and the average inter-item correlation 0.38. The Danish version formed a unidimensional, probabilistic Guttman-like scale explaining 43.2% of the variance. We did however, find a different item sequence compared to the original scale. CONCLUSION: A Danish version of PAM13 with acceptable validity and reliability is now available. Further development should focus on single items, response categories in relation to ceiling effects and further validation of reproducibility and responsiveness.
format Text
id pubmed-2712471
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27124712009-07-18 Translation, adaptation and validation of the American short form Patient Activation Measure (PAM13) in a Danish version Maindal, Helle Terkildsen Sokolowski, Ineta Vedsted, Peter BMC Public Health Research Article BACKGROUND: The Patient Activation Measure (PAM) is a measure that assesses patient knowledge, skill, and confidence for self-management. This study validates the Danish translation of the 13-item Patient Activation Measure (PAM13) in a Danish population with dysglycaemia. METHODS: 358 people with screen-detected dysglycaemia participating in a primary care health education study responded to PAM13. The PAM13 was translated into Danish by a standardised forward-backward translation. Data quality was assessed by mean, median, item response, missing values, floor and ceiling effects, internal consistency (Cronbach's alpha and average inter-item correlation) and item-rest correlations. Scale properties were assessed by Rasch Rating Scale models. RESULTS: The item response was high with a small number of missing values (0.8–4.2%). Floor effect was small (range 0.6–3.6%), but the ceiling effect was above 15% for all items (range 18.6–62.7%). The α-coefficient was 0.89 and the average inter-item correlation 0.38. The Danish version formed a unidimensional, probabilistic Guttman-like scale explaining 43.2% of the variance. We did however, find a different item sequence compared to the original scale. CONCLUSION: A Danish version of PAM13 with acceptable validity and reliability is now available. Further development should focus on single items, response categories in relation to ceiling effects and further validation of reproducibility and responsiveness. BioMed Central 2009-06-29 /pmc/articles/PMC2712471/ /pubmed/19563630 http://dx.doi.org/10.1186/1471-2458-9-209 Text en Copyright © 2009 Maindal et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Maindal, Helle Terkildsen
Sokolowski, Ineta
Vedsted, Peter
Translation, adaptation and validation of the American short form Patient Activation Measure (PAM13) in a Danish version
title Translation, adaptation and validation of the American short form Patient Activation Measure (PAM13) in a Danish version
title_full Translation, adaptation and validation of the American short form Patient Activation Measure (PAM13) in a Danish version
title_fullStr Translation, adaptation and validation of the American short form Patient Activation Measure (PAM13) in a Danish version
title_full_unstemmed Translation, adaptation and validation of the American short form Patient Activation Measure (PAM13) in a Danish version
title_short Translation, adaptation and validation of the American short form Patient Activation Measure (PAM13) in a Danish version
title_sort translation, adaptation and validation of the american short form patient activation measure (pam13) in a danish version
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2712471/
https://www.ncbi.nlm.nih.gov/pubmed/19563630
http://dx.doi.org/10.1186/1471-2458-9-209
work_keys_str_mv AT maindalhelleterkildsen translationadaptationandvalidationoftheamericanshortformpatientactivationmeasurepam13inadanishversion
AT sokolowskiineta translationadaptationandvalidationoftheamericanshortformpatientactivationmeasurepam13inadanishversion
AT vedstedpeter translationadaptationandvalidationoftheamericanshortformpatientactivationmeasurepam13inadanishversion